when will retatrutide be available Promises Big Weight Loss, but Safety Remains a Question When Will Retatrutide Be FDA

Moreover, over time, patients with T2DM have significantly faster progression of motor symptoms, worse depression scores, and are more likely to develop substantial gait impairment and mild cognitive impairment than patients without T2DM [53, 54]

And it promotes satiety, extending the appetite suppression effects of tirzepatide

Trimsulin vs

Pendulum plus other probiotics

During GLP-1 treatment , contact your GP if you experience: Severe or persistent abdominal pain , particularly if different in character from your usual IBS symptoms or if radiating to your back (which may indicate pancreatitisstop the medication and seek urgent medical attention) Significant worsening of diarrhoea or constipation that doesn't improve with standard measures Persistent nausea or vomiting affecting your ability to maintain adequate nutrition and hydration New symptoms such as rectal bleeding, unintentional weight loss (beyond expected therapeutic effect), or nocturnal symptoms waking you from sleep Difficulty distinguishing between IBS symptoms and medication side effects Sudden pain in the upper right abdomen, fever, or yellowing of the skin/eyes (possible gallbladder diseaseseek urgent medical attention) Red flag symptoms requiring urgent medical attention include: Severe, unremitting abdominal pain Rectal bleeding or black, tarry stools Unexplained weight loss Persistent vomiting with inability to keep fluids down Signs of dehydration Your GP may arrange appropriate investigations such as blood tests (full blood count, inflammatory markers, coeliac serology) or faecal calprotectin testing to distinguish IBS from inflammatory bowel disease where appropriate

To be clear, the evidence linking GLP-1 agonists to gastroparesis and pancreatitis is suggestive, not definitive